South Korea
# |
Name |
EBIT |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 923.20 M
|
Dec. 31, 2023 | USD 745.69 | 1.15% |
|
South Korea |
|
2 |
USD 531.40 M
|
Dec. 31, 2023 | USD 119.86 | -2.20% |
|
South Korea |
|
3 |
USD 192.45 M
|
Dec. 31, 2023 | USD 56.39 | -4.53% |
|
South Korea |
|
4 |
USD 172.71 M
|
Dec. 31, 2023 | USD 159.35 | -4.24% |
|
South Korea |
|
5 |
USD 165.98 M
|
Dec. 31, 2023 | USD 13.69 | -2.57% |
|
South Korea |
|
6 |
USD 101.74 M
|
Dec. 31, 2023 | USD 23.36 | -2.28% |
|
South Korea |
|
7 |
USD 93.02 M
|
Dec. 31, 2023 | USD 89.76 | -4.42% |
|
South Korea |
|
8 |
USD 63.55 M
|
Dec. 31, 2023 | USD 83.97 | -5.00% |
|
South Korea |
|
9 |
USD 56.25 M
|
Dec. 31, 2023 | USD 18.22 | -3.57% |
|
South Korea |
|
10 |
USD 53.19 M
|
Dec. 31, 2023 | USD 12.66 | -2.66% |
|
South Korea |
|
11 |
USD 51.91 M
|
Dec. 31, 2023 | USD 9.85 | -4.50% |
|
South Korea |
|
12 |
USD 51.61 M
|
Dec. 31, 2023 | USD 65.38 | -0.04% |
|
South Korea |
|
13 |
USD 51.28 M
|
Dec. 31, 2023 | USD 15.49 | -2.92% |
|
South Korea |
|
14 |
USD 50.58 M
|
Dec. 31, 2023 | USD 6.82 | -1.91% |
|
South Korea |
|
15 |
USD 41.88 M
|
Dec. 31, 2023 | USD 3.69 | -1.06% |
|
South Korea |
|
16 |
USD 34.20 M
|
Dec. 31, 2023 | USD 5.23 | -2.06% |
|
South Korea |
|
17 |
USD 29.41 M
|
Dec. 31, 2023 | USD 16.51 | 0.47% |
|
South Korea |
|
18 |
USD 26.76 M
|
Dec. 31, 2023 | USD 4.07 | -1.95% |
|
South Korea |
|
19 |
USD 26.73 M
|
Dec. 31, 2023 | USD 7.90 | -1.67% |
|
South Korea |
|
20 |
USD 26.50 M
|
Dec. 31, 2023 | USD 34.59 | -4.65% |
|
South Korea |
|
21 |
USD 26.04 M
|
Dec. 31, 2023 | USD 88.80 | -5.65% |
|
South Korea |
|
22 |
USD 24.56 M
|
Dec. 31, 2023 | USD 11.00 | -3.03% |
|
South Korea |
|
23 |
USD 22.99 M
|
Dec. 31, 2023 | USD 9.80 | -1.72% |
|
South Korea |
|
24 |
USD 22.63 M
|
Dec. 31, 2023 | USD 54.68 | -7.62% |
|
South Korea |
|
25 |
USD 15.60 M
|
Dec. 31, 2023 | USD 33.57 | -2.13% |
|
South Korea |
|
26 |
USD 15.35 M
|
Dec. 31, 2023 | USD 11.62 | -0.90% |
|
South Korea |
|
27 |
USD 13.92 M
|
Dec. 31, 2023 | USD 11.86 | -0.20% |
|
South Korea |
|
28 |
USD 13.30 M
|
Dec. 31, 2023 | USD 77.77 | -3.69% |
|
South Korea |
|
29 |
USD 13.06 M
|
Dec. 31, 2023 | USD 31.05 | -1.12% |
|
South Korea |
|
30 |
USD 12.56 M
|
Dec. 31, 2023 | USD 7.21 | -0.62% |
|
South Korea |
|
31 |
USD 10.74 M
|
Dec. 31, 2023 | USD 4.14 | -7.03% |
|
South Korea |
|
32 |
USD 9.66 M
|
Dec. 31, 2023 | USD 7.87 | -2.10% |
|
South Korea |
|
33 |
USD 9.53 M
|
Dec. 31, 2023 | USD 9.81 | -0.42% |
|
South Korea |
|
34 |
USD 7.01 M
|
Dec. 31, 2023 | USD 2.87 | -2.35% |
|
South Korea |
|
35 |
USD 6.81 M
|
Dec. 31, 2023 | USD 1.89 | -1.74% |
|
South Korea |
|
36 |
USD 6.70 M
|
Dec. 31, 2023 | USD 32.21 | -3.61% |
|
South Korea |
|
37 |
USD 5.95 M
|
Dec. 31, 2023 | USD 15.36 | -2.10% |
|
South Korea |
|
38 |
USD 5.18 M
|
Dec. 31, 2023 | USD 7.33 | -4.07% |
|
South Korea |
|
39 |
USD 4.95 M
|
Dec. 31, 2023 | USD 3.22 | 0.07% |
|
South Korea |
|
40 |
USD 4.30 M
|
Dec. 31, 2023 | USD 5.00 | -8.15% |
|
South Korea |
|
41 |
USD 3.82 M
|
Dec. 31, 2023 | USD 8.58 | -5.12% |
|
South Korea |
|
42 |
USD 3.25 M
|
Dec. 31, 2023 | USD 8.44 | -2.89% |
|
South Korea |
|
43 |
USD 2.33 M
|
Dec. 31, 2023 | USD 1.18 | -3.42% |
|
South Korea |
|
44 |
USD 1.20 M
|
Dec. 31, 2023 | USD 15.77 | -2.26% |
|
South Korea |
|
45 |
USD 1.03 M
|
Dec. 31, 2023 | USD 11.53 | -7.22% |
|
South Korea |
|
46 |
USD 275.27 K
|
Dec. 31, 2023 | USD 1.12 | -3.94% |
|
South Korea |
|
47 |
USD -380.94 K
|
Dec. 31, 2023 | USD 25.27 | 1.91% |
|
South Korea |
|
48 |
USD -575.19 K
|
Dec. 31, 2023 | USD 3.01 | -3.95% |
|
South Korea |
|
49 |
USD -800.94 K
|
Dec. 31, 2023 | USD 1.37 | -0.64% |
|
South Korea |
|
50 |
USD -973.97 K
|
Dec. 31, 2023 | USD 11.83 | -21.52% |
|
South Korea |
The Healthcare company in South Korea with the highest EBIT is Samsung Biologics Co.,Ltd. (KSE: 207940.KS) at USD 923.20 M.
The Healthcare company in South Korea with the lowest EBIT is SD BioSensor, Inc (KSE: 137310.KS) at USD -298.29 M.
The top 10 Healthcare companies in South Korea by EBIT are Samsung Biologics Co.,Ltd., Celltrion, Inc., Chong Kun Dang Pharmaceutical Corp., Hanmi Pharm. Co., Ltd., Daewoong Co., Ltd., Huons Global Co., Ltd., Daewoong pharmaceutical Co.,Ltd, Yuhan Corporation, Hanmi Science Co., Ltd. and Value Added Technology Co., Ltd..
The bottom 10 Healthcare companies in South Korea by EBIT are SD BioSensor, Inc, GeneOne Life Science, Inc., Aprogen pharmaceuticals,Inc., Helixmith Co., Ltd, Shin Poong Pharm.Co.,Ltd., EOFLOW Co.,Ltd., CrystalGenomics, Inc., Genexine, Inc., SK Biopharmaceuticals Co., Ltd. and Bukwang Pharmaceutical Co., Ltd..